Literature DB >> 7565956

Long-term therapy for reflux esophagitis.

G N Tytgat.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565956     DOI: 10.1056/NEJM199510263331711

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Cost analysis of a provincial drug program to guide the treatment of upper gastrointestinal disorders.

Authors:  F Bursey; M Crowley; C Janes; C J Turner
Journal:  CMAJ       Date:  2000-03-21       Impact factor: 8.262

2.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

3.  Supplementation of Los Angeles classification with esophageal mucosa index of hemoglobin can predict the treatment response of erosive reflux esophagitis.

Authors:  Hsin Cheng; Yu-Ching Tsai; Wei-Ying Chen; Wei-Lun Chang; Hsiu-Chi Cheng; Bor-Shyang Sheu
Journal:  Surg Endosc       Date:  2011-02-07       Impact factor: 4.584

Review 4.  Medical management of nocturnal symptoms of gastro-oesophageal reflux disease in the elderly.

Authors:  Samer Gawrieh; Reza Shaker
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

5.  Early laparoscopic Nissen fundoplication for recurrent reflux esophagitis: a cost-effective alternative to omeprazole.

Authors:  S C Nessen; J Holcomb; B Tonkinson; S P Hetz; M A Schreiber
Journal:  JSLS       Date:  1999 Apr-Jun       Impact factor: 2.172

Review 6.  Medical therapy of gastroesophageal reflux disease in secondary and tertiary care settings.

Authors:  G N Tytgat
Journal:  Yale J Biol Med       Date:  1999 Mar-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.